Key facts
- This page summarizes Glenn Coleman's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Mar 2024, 16:33.
Glenn Coleman - 04 Mar 2024 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)
- Reporting relationship
- Executive VP & CFO
- Issuer ticker
- XRAY
- Reported as of
- 04 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2024, 16:33:44 UTC
- Prior SEC filing
- 04 Mar 2024
- Next SEC filing
- 19 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dane Baumgardner, Attorney-In-Fact for Glenn Coleman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Glenn Coleman filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 06 Mar 2024.
Change
- Previous filing in this sequence was filed on 04 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XRAY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +18,780
- Change %
- +27%
- Price
- $0.000000
- Shares after
- 88,449
- Date
- 04 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XRAY
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +62,800
- Change %
- Price
- $0.000000
- Shares after
- 62,800
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 62,800
- Exercise price
- $33.28
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/4/2027.
Footnote F2
Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 4, 2027.